These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37444611)

  • 1. The Evolving Approach to Breast Cancer: Moving toward De-Escalating Treatment and Personalized Medicine.
    Khoury T
    Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer.
    Gianni C; Palleschi M; Merloni F; Bleve S; Casadei C; Sirico M; Di Menna G; Sarti S; Cecconetto L; Mariotti M; De Giorgi U
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The next generation personalized models to screen hidden layers of breast cancer tumorigenicity.
    Afzali F; Akbari P; Naderi-Manesh H; Gardaneh M
    Breast Cancer Res Treat; 2019 Jun; 175(2):277-286. PubMed ID: 30810866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast Cancer Prognostic Hub Genes Identified by Integrated Transcriptomic and Weighted Network Analysis: A Road Toward Personalized Medicine.
    Singh P; Rathi A; Minocha R; Sinha A; Haque MM; Hassan MI; Dohare R
    OMICS; 2023 May; 27(5):227-236. PubMed ID: 37155625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Moving toward personalized breast cancer screening: The role of Primary Care].
    Pons-Rodriguez A; Marzo-Castillejo M; Cruz-Esteve I; Galindo-Ortego G; Hernández-Leal MJ; Rué M
    Aten Primaria; 2022 May; 54(5):102288. PubMed ID: 35477080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics'.
    Mehmood S; Faheem M; Ismail H; Farhat SM; Ali M; Younis S; Asghar MN
    Front Mol Biosci; 2022; 9():783494. PubMed ID: 35495618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast Cancer in Young Women: Status Quo and Advanced Disease Management by a Predictive, Preventive, and Personalized Approach.
    Kudela E; Samec M; Kubatka P; Nachajova M; Laucekova Z; Liskova A; Dokus K; Biringer K; Simova D; Gabonova E; Dankova Z; Biskupska Bodova K; Zubor P; Trog D
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31739537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Subtype May Be More Associated With Prognosis and Chemotherapy Benefit Than Tumor Size in T1N0 Breast Cancer Patients: An Analysis of 2,168 Patients for Possible De-Escalation Treatment.
    Zhu S; Li Y; Chen W; Fei X; Shen K; Chen X
    Front Oncol; 2021; 11():636266. PubMed ID: 33680973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Strategies on Personalized Medicine for Breast Cancer Treatment: An Update.
    Chan CWH; Law BMH; So WKW; Chow KM; Waye MMY
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29140300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral Blood Transcriptome in Breast Cancer Patients as a Source of Less Invasive Immune Biomarkers for Personalized Medicine, and Implications for Triple Negative Breast Cancer.
    Čelešnik H; Potočnik U
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Sensitivity of Breast Cancer Cell Lines to Cardiac Glycosides Unveils ATP1B3 as a Possible Biomarker for the Personalized Treatment of ERα Expressing Breast Cancers.
    Acconcia F
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTC enumeration and characterization: moving toward personalized medicine.
    Toss A; Mu Z; Fernandez S; Cristofanilli M
    Ann Transl Med; 2014 Nov; 2(11):108. PubMed ID: 25489582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical perspective on escalating or de-escalating adjuvant therapy in HER2+ breast cancer.
    Esposito A; Viale G; Criscitiello C; Curigliano G
    Expert Rev Clin Pharmacol; 2019 Jan; 12(1):9-16. PubMed ID: 30466330
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular Breast Cancer Imaging in the Era of Precision Medicine.
    Muzahir S
    AJR Am J Roentgenol; 2020 Dec; 215(6):1512-1519. PubMed ID: 33084364
    [No Abstract]   [Full Text] [Related]  

  • 15. From technological advances to biological understanding: The main steps toward high-precision RT in breast cancer.
    Leonardi MC; Ricotti R; Dicuonzo S; Cattani F; Morra A; Dell'Acqua V; Orecchia R; Jereczek-Fossa BA
    Breast; 2016 Oct; 29():213-22. PubMed ID: 27542556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach.
    Uramova S; Kubatka P; Dankova Z; Kapinova A; Zolakova B; Samec M; Zubor P; Zulli A; Valentova V; Kwon TK; Solar P; Kello M; Kajo K; Busselberg D; Pec M; Danko J
    EPMA J; 2018 Dec; 9(4):403-419. PubMed ID: 30538792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Major Transcriptomics and Epitranscriptomics Contributions toward Personalized and Precision Medicine.
    Mubarak G; Zahir FR
    J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comprehensive analysis of the efficacy of personalized rehabilitation programs in patients with breast cancer].
    Kasparov BS; Kovlen DV; Semiglazova TY; Kondratieva KO; Ponomarenko GN; Kluge VA; Semiglazov VV; Frolov ON; Riazankina AA; Beliaev AM
    Vopr Kurortol Fizioter Lech Fiz Kult; 2023; 100(2):31-38. PubMed ID: 37141520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local Disease-Free Survival Rate (LSR) Application to Personalize Radiation Therapy Treatments in Breast Cancer Models.
    Savoca G; Calvaruso M; Minafra L; Bravatà V; Cammarata FP; Iacoviello G; Abbate B; Evangelista G; Spada M; Forte GI; Russo G
    J Pers Med; 2020 Oct; 10(4):. PubMed ID: 33080870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving standards of care and new challenges in the management of HER2-positive breast cancer.
    Choong GM; Cullen GD; O'Sullivan CC
    CA Cancer J Clin; 2020 Sep; 70(5):355-374. PubMed ID: 32813307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.